Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boldt is a senior-led strategy and communications consultancy that specializes in the healthcare, life sciences, and pharmaceutical sectors. The firm provides high-level advisory services in corporate affairs, public policy, market access, and reputation management, helping clients navigate complex regulatory environments across Europe and globally. In March 2024, Boldt was acquired by Edelman, the world's largest communications firm, to significantly enhance its strategic advisory and public affairs capabilities in the European market. The consultancy is recognized for its senior-led approach, where partners directly manage client engagements to solve complex business, political, and societal challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boldt Consulting.